Chemokines and cytokines in immunotherapy of melanoma and other tumors: from biomarkers to therapeutic targets

Chemokines and cytokines represent an emerging field of immunotherapy research. They are responsible for the crosstalk and chemoattraction of immune cells and tumor cells. For instance, CXCL9/10/11 chemoattract effector CD8+ T cells to the tumor microenvironment, making an argument for their promisi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Reschke, Robin Niklas (VerfasserIn) , Enk, Alexander (VerfasserIn) , Hassel, Jessica C. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 13 June 2024
In: International journal of molecular sciences
Year: 2024, Jahrgang: 25, Heft: 12, Pages: 1-17
ISSN:1422-0067
DOI:10.3390/ijms25126532
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.3390/ijms25126532
Verlag, kostenfrei, Volltext: https://www.mdpi.com/1422-0067/25/12/6532
Volltext
Verfasserangaben:Robin Reschke, Alexander H. Enk and Jessica C. Hassel

MARC

LEADER 00000caa a2200000 c 4500
001 1916150381
003 DE-627
005 20250716225728.0
007 cr uuu---uuuuu
008 250203s2024 xx |||||o 00| ||eng c
024 7 |a 10.3390/ijms25126532  |2 doi 
035 |a (DE-627)1916150381 
035 |a (DE-599)KXP1916150381 
035 |a (OCoLC)1528018373 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Reschke, Robin Niklas  |d 1989-  |e VerfasserIn  |0 (DE-588)113859038X  |0 (DE-627)896092011  |0 (DE-576)492596956  |4 aut 
245 1 0 |a Chemokines and cytokines in immunotherapy of melanoma and other tumors  |b from biomarkers to therapeutic targets  |c Robin Reschke, Alexander H. Enk and Jessica C. Hassel 
264 1 |c 13 June 2024 
300 |b Illustrationen 
300 |a 17 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.02.2025 
520 |a Chemokines and cytokines represent an emerging field of immunotherapy research. They are responsible for the crosstalk and chemoattraction of immune cells and tumor cells. For instance, CXCL9/10/11 chemoattract effector CD8+ T cells to the tumor microenvironment, making an argument for their promising role as biomarkers for a favorable outcome. The cytokine Interleukin-15 (IL-15) can promote the chemokine expression of CXCR3 ligands but also XCL1, contributing to an important DC-T cell interaction. Recruited cytotoxic T cells can be clonally expanded by IL-2. Delivering or inducing these chemokines and cytokines can result in tumor shrinkage and might synergize with immune checkpoint inhibition. In addition, blocking specific chemokine and cytokine receptors such as CCR2, CCR4 or Il-6R can reduce the recruitment of tumor-associated macrophages (TAMs), myeloid-derived suppressor cells (MDSCs) or regulatory T cells (Tregs). Efforts to target these chemokines and cytokines have the potential to personalize cancer immunotherapy further and address patients that are not yet responsive because of immune cell exclusion. Targeting cytokines such as IL-6 and IL-15 is currently being evaluated in clinical trials in combination with immune checkpoint-blocking antibodies for the treatment of metastatic melanoma. The improved overall survival of melanoma patients might outweigh potential risks such as autoimmunity. However, off-target toxicity needs to be elucidated. 
650 4 |a chemokines 
650 4 |a cytokines 
650 4 |a immunotherapy 
650 4 |a tumor microenvironment 
700 1 |a Enk, Alexander  |d 1963-  |e VerfasserIn  |0 (DE-588)1032757140  |0 (DE-627)739272535  |0 (DE-576)166173517  |4 aut 
700 1 |a Hassel, Jessica C.  |d 1975-  |e VerfasserIn  |0 (DE-588)129790702  |0 (DE-627)480399069  |0 (DE-576)29783715X  |4 aut 
773 0 8 |i Enthalten in  |t International journal of molecular sciences  |d Basel : Molecular Diversity Preservation International, 2000  |g 25(2024), 12, Artikel-ID 6532, Seite 1-17  |h Online-Ressource  |w (DE-627)316340715  |w (DE-600)2019364-6  |w (DE-576)281194653  |x 1422-0067  |7 nnas  |a Chemokines and cytokines in immunotherapy of melanoma and other tumors from biomarkers to therapeutic targets 
773 1 8 |g volume:25  |g year:2024  |g number:12  |g elocationid:6532  |g pages:1-17  |g extent:17  |a Chemokines and cytokines in immunotherapy of melanoma and other tumors from biomarkers to therapeutic targets 
856 4 0 |u https://doi.org/10.3390/ijms25126532  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.mdpi.com/1422-0067/25/12/6532  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250203 
993 |a Article 
994 |a 2024 
998 |g 129790702  |a Hassel, Jessica C.  |m 129790702:Hassel, Jessica C.  |d 910000  |d 911300  |d 50000  |e 910000PH129790702  |e 911300PH129790702  |e 50000PH129790702  |k 0/910000/  |k 1/910000/911300/  |k 0/50000/  |p 3  |y j 
998 |g 1032757140  |a Enk, Alexander  |m 1032757140:Enk, Alexander  |d 910000  |d 911300  |e 910000PE1032757140  |e 911300PE1032757140  |k 0/910000/  |k 1/910000/911300/  |p 2 
998 |g 113859038X  |a Reschke, Robin Niklas  |m 113859038X:Reschke, Robin Niklas  |d 910000  |d 911300  |e 910000PR113859038X  |e 911300PR113859038X  |k 0/910000/  |k 1/910000/911300/  |p 1  |x j 
999 |a KXP-PPN1916150381  |e 4659933555 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"subtitle":"from biomarkers to therapeutic targets","title_sort":"Chemokines and cytokines in immunotherapy of melanoma and other tumors","title":"Chemokines and cytokines in immunotherapy of melanoma and other tumors"}],"person":[{"family":"Reschke","display":"Reschke, Robin Niklas","given":"Robin Niklas","role":"aut"},{"family":"Enk","given":"Alexander","display":"Enk, Alexander","role":"aut"},{"family":"Hassel","role":"aut","display":"Hassel, Jessica C.","given":"Jessica C."}],"physDesc":[{"extent":"17 S.","noteIll":"Illustrationen"}],"id":{"eki":["1916150381"],"doi":["10.3390/ijms25126532"]},"language":["eng"],"name":{"displayForm":["Robin Reschke, Alexander H. Enk and Jessica C. Hassel"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1916150381","relHost":[{"recId":"316340715","origin":[{"publisherPlace":"Basel","publisher":"Molecular Diversity Preservation International","dateIssuedDisp":"2000-","dateIssuedKey":"2000"}],"note":["Gesehen am 17.09.20"],"pubHistory":["1.2000 -"],"id":{"eki":["316340715"],"zdb":["2019364-6"],"issn":["1422-0067","1661-6596"]},"language":["eng"],"titleAlt":[{"title":"IJMS"}],"part":{"extent":"17","volume":"25","issue":"12","pages":"1-17","year":"2024","text":"25(2024), 12, Artikel-ID 6532, Seite 1-17"},"title":[{"title":"International journal of molecular sciences","title_sort":"International journal of molecular sciences"}],"disp":"Chemokines and cytokines in immunotherapy of melanoma and other tumors from biomarkers to therapeutic targetsInternational journal of molecular sciences","physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"}}],"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"13 June 2024"}],"note":["Gesehen am 03.02.2025"]} 
SRT |a RESCHKEROBCHEMOKINES1320